Tebapivat

tebapivat · Agios Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Tebapivat, covering 2025-03-18 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) [Phase 2]

See pricing